VISTAGEN THERAPEUTICS, INC. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- VISTAGEN THERAPEUTICS, INC. stock issued during period, value, issued for services for the quarter ending 2020-06-30 was $125.00K.
- VISTAGEN THERAPEUTICS, INC. stock issued during period, value, issued for services for the quarter ending 2018-09-30 was $334.90K.
- VISTAGEN THERAPEUTICS, INC. stock issued during period, value, issued for services for the quarter ending 2018-06-30 was $123.00K.
- VISTAGEN THERAPEUTICS, INC. stock issued during period, value, issued for services for the quarter ending 2018-03-31 was $39.00K.
- VISTAGEN THERAPEUTICS, INC. stock issued during period, value, issued for services for fiscal 2021 was $125.00K.
- VISTAGEN THERAPEUTICS, INC. stock issued during period, value, issued for services for fiscal 2019 was $499.50K, a 71.18% decline from fiscal 2018.
- VISTAGEN THERAPEUTICS, INC. stock issued during period, value, issued for services for fiscal 2018 was $1.73M, a 7.83% decline from fiscal 2017.
- VISTAGEN THERAPEUTICS, INC. stock issued during period, value, issued for services for fiscal 2017 was $1.88M.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2021-03-31 | $125.00K 10-K · filed 2022-06-23 | |
| 2020-06-30 | $125.00K 10-Q · filed 2022-02-10 | |
| 2019-03-31 | $499.50K 10-K · filed 2020-06-29 | |
| 2018-09-30 | $334.90K 10-Q · filed 2020-02-13 | |
| 2018-06-30 | $123.00K 10-Q · filed 2020-02-13 | |
| 2018-03-31 | $39.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-06-25 | $1.73M 10-K · filed 2019-06-25 |
| 2017-03-31 | $1.88M 10-K · filed 2018-06-26 | |
| 2015-03-31 | $635.70K 10-K · filed 2016-06-24 | |
| 2013-03-31 | $340.00K 10-K · filed 2014-06-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |